Consequently, macrophage metabolism is often abnormal in disease states, and their loss of FOXO3-mediated metabolic reprogramming presents a potential therapeutic target for colonic inflammation and tumorigenesis facilitated by obesity. This evidence concerns the gene FOXO3 and Obesity.